These phenotypes imply an increase in the severity of colitis in the colons of the DSS- or TNBS- treated CarinhKO mice, lending support for the clinical findings from human genetics studies, which have linked CARINH with IBD pathogenesis. Here, CARINH is linked to inflammatory bowel disease.